Estradiol valerate/levomefolate

Drug Profile

Estradiol valerate/levomefolate

Alternative Names: BAY 987078

Latest Information Update: 02 Feb 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bayer HealthCare Pharmaceuticals
  • Class Estradiol congeners; Estrenes; Folic-acids; Hormonal contraceptives; Hormonal replacements; Oral contraceptives; Vitamins
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Pregnancy

Most Recent Events

  • 02 Feb 2015 No development reported - Phase-I for Pregnancy (Prevention) in Germany (PO)
  • 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals
  • 13 Mar 2010 Bayer completes a phase I trial in Contraception/Pregnancy (Prevention) in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top